191.034 articles found

Serotonin innervation of the subthalamic nucleus in parkinsonian monkeys.

Delmas CVL, Munro J, Bérard M, Di Paolo T, Morissette M, Tremblay ME, Parent A, Parent M.

Neurobiol Dis · 2025-05-02

DOI: 10.1016/j.nbd.2025.106938PMID: 40320179

Burden of neurological disorders in China and its provinces, 1990-2021: Findings from the global burden of disease study 2021.

Zhang C, Yang X, Wan D, Ma Q, Yin P, GBD 2021 China Neurological Disorders Collaborators, Zhou M, Hao J.

Med · 2025-05-02

DOI: 10.1016/j.medj.2025.100692PMID: 40315853

Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson's disease.

Ayerra L, Abellanas MA, Vidaurre C, Basurco L, Tavira A, Luquin E, Clavero P, Mengual E, Collantes M, Peñuelas I, de Martin-Esteban SR, Grether U, Hillard CJ, Romero J, Hervás-Stubbs S, Aymerich MS.

Brain Behav Immun · 2025-05-02

DOI: 10.1016/j.bbi.2025.04.037PMID: 40320016

TRPM8 activation inhibits neuroinflammation and ameliorates neurodegeneration by modulating Nrf2/HO-1 and NF-κB pathways in vivo and in vitro.

Gao X, Fu S, Liu Y, Yan A, Sun Y, Li X, Liu D, He D.

Free Radic Biol Med · 2025-05-02

DOI: 10.1016/j.freeradbiomed.2025.04.049PMID: 40320219

Leaf miRNAs of Withania somnifera Negatively Regulate the Aging-Associated Genes in C. elegans.

Yadav S, Gupta RK, Kumar S, Rizvi A, Tyagi D, Satish A, Verma D, Vishwakarma A, Saxena S.

Mol Neurobiol · 2025-05-02

DOI: 10.1007/s12035-025-04995-2PMID: 40314900

Inhibiting mitochondrial excessive fission alleviates the neuronal damage in Parkinson's disease via regulating PGC-1α mediated mitochondrial biogenesis.

Ma J, Yang Y, Zang C, Chen Q, Jiang Y, Dong Y, Wang J, Zhou N, Yang X, Li F, Bao X, Zhang D.

Exp Neurol · 2025-05-02

DOI: 10.1016/j.expneurol.2025.115288PMID: 40320116

Advances in biosensors for diagnosis of Alzheimer's and Parkinson's diseases.

Negahdary M, Sakthinathan I, Mirsadoughi E, Ligler FS, Coté GL, Forster RJ, Mabbott S.

Biosens Bioelectron · 2025-05-02

DOI: 10.1016/j.bios.2025.117535PMID: 40349564

The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson's disease.

Barker RA, Lao-Kaim NP, Guzman NV, Athauda D, Bjartmarz H, Björklund A, Church A, Cutting E, Daft D, Dayal V, Dunnett S, Evans A, Grealish S, Hannaway N, He X, Hewitt S, Kefalopoulou Z, Mahlknecht P, Martín-Bastida A, Farrell K, Moore S, Bulstrode H, Nakornchai T, Nelander-Wahlestedt J, Roupé L, Paul G, Peall K, Rosser A, Roca-Fernández A, Rowlands S, McGorrian AM, Scherf C, Vinh NN, Roberton V, Kelly C, Lelos M, Torres E, Shires K, Hills R, Williams D, Roussakis AA, Sibley K, Tyers P, Wijeyekoon R, Williams-Gray C, Foltynie T, Piccini P, Morris R, Lazic SE, Lindvall O, Parmar M, Widner H, TransEuro consortium.

Nat Biotechnol · 2025-05-02

DOI: 10.1038/s41587-025-02567-2PMID: 40316701

Mental Wellbeing and its Determinants in People with Parkinson's Disease in Ethiopia: A Mixed-Method Study.

Alenko A, Morankar S, Chelkeba L, Seyoum SA, Uka YY, Keygnaert I.

J Geriatr Psychiatry Neurol · 2025-05-02

DOI: 10.1177/08919887251339836PMID: 40317100

Effects of a Remote Mental and Physical Practice Intervention on Freezing of Gait in People with Parkinson’s Disease: a Single-Blind Randomized Controlled Trial Protocol

Rodrigues da Silva P, Tashima Honda KY, Rigolin Pikel M, Rodrigues dos Santos A, Pimentel Piemonte ME.

· 2025-05-01

DOI: 10.1101/2025.04.28.25326452

Does reduced reactivity explain altered postural control in Parkinson’s disease? A predictive simulation study

Shanbhag J, Fleischmann S, Wechsler I, Gassner H, Winkler J, Eskofier BM, Koelewijn AD, Wartzack S, Miehling J.

· 2025-05-01

DOI: 10.1101/2025.04.30.651447

Trends in determining carbamates and dithiocarbamates in food samples

Martins FCOL, Melchert WR.

Journal of food composition and analysis : an official publication of the United Nations University, International Network of Food Data Systems · 2025-05-01